DR. NATALIE HALE WALLACE (MD, MPH) – Hematology & Oncology Physician, NPI 1386059061
Hematology & Oncology Physician
Main info
Doctor Profile
Contacts
Profile Insights
NPPES metrics only — not quality of care.
20 HEMATOLOGY/ONCOLOGY in AK
Provider Addresses for DR. NATALIE HALE WALLACE (MD, MPH)
2925 DEBARR RD STE 300
ANCHORAGE, AK 995082974
Phone: (907) 279-3155
Fax: (907) 279-3154
Type: Location
3851 PIPER STREET SUITE U340
ANCHORAGE, AK 99508
Phone: (907) 562-0321
Fax: (907) 562-2683
Type: Mailing
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 145 Open Payments records for all available years, with a total value of $3,457.
Total Amount is formed as General ($3,457) + Research ($0) + Ownership ($0) = $3,457.
Last reported payment date: 2024-12-18 • Largest payer in this snapshot: AstraZeneca Pharmaceuticals LP ($432).
Total Amount
$3,457
General + Research + Ownership
Payments
145
Total payment records
General Amount
$3,457
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-12-18
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| AstraZeneca Pharmaceuticals LP | $432 |
| Janssen Biotech, Inc. | $385 |
| ABBVIE INC. | $230 |
| Novartis Pharmaceuticals Corporation | $218 |
| Seagen Inc. | $135 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
PECOS enrollment status
Participating (accepts Medicare assignment)
Enrollment effective: 2020-09-11
PECOS data refreshed: 2026-05-27
Medicare revalidation (CMS due date list)
Due date not assigned yet
CMS is tracking this Medicare enrollment for revalidation, but has not published a due date.
Enrollment records
1
Earliest due date
Not assigned (TBD)
CMS data updated
2026-06-01
Revalidation progress
- Medicare enrolled
- On CMS revalidation list
- Due date assigned
- Revalidate in PECOS
CMS enrollment records
| Enrollment ID | Type | Specialty | State | Due date |
|---|---|---|---|---|
| I20200911000323 | I | Hematology/Oncology | AK | TBD |
What to do next
- No action required while the due date shows TBD.
- Check the CMS Revalidation Lookup Tool periodically — CMS updates the list about every 60 days.
- Do not submit a revalidation application in PECOS until CMS publishes a concrete due date.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 19,000 | 27 | $0 |
| J0897 | Injection, denosumab, 1 mg | 5,520 | 21 | $0 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 4,680 | 28 | $0 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,934 | 46 | $0 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 1,790 | 47 | $0 |
Insurance plans in this area (ZIP 99508)
Loading plans...
Group practice members
| Name | Specialty | State |
|---|---|---|
| Hematology/Oncology, Internal Medicine | AK | |
| Internal Medicine, Hematology/Oncology | AK | |
| Nurse Practitioner | AK | |
| Nurse Practitioner | AK | |
| Nurse Practitioner | HI | |
| Hematology, Hematology/Oncology | AK | |
| - | AK | |
| Hematology/Oncology, Hematology, Internal Medicine, Medical Oncology, Medical Oncology | AK | |
| Medical Oncology | AK | |
| H E M A T O L O G Y/ O N C O L O G Y | AK |
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.